NanoViricides
NNVC
#10102
Rank
โ‚น2.21 B
Marketcap
โ‚น123.22
Share price
-4.20%
Change (1 day)
-2.53%
Change (1 year)

EPS for NanoViricides (NNVC)

EPS in 2025 (TTM): -โ‚น56.59

According to NanoViricides's latest financial reports the company's current EPS (TTM) is -โ‚น60.26. In 2024 the company made an earnings per share (EPS) of -โ‚น62.96 an increase over its 2023 EPS that were of -โ‚น66.56.

EPS history for NanoViricides from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น56.59-10.11%
2024-โ‚น62.96-5.41%
2023-โ‚น66.565.71%
2022-โ‚น62.96-13.58%
2021-โ‚น72.86-66.11%
2020-โ‚น214.971.7%
2019-โ‚น211.37-10.98%
2018-โ‚น237.45-22.35%
2017-โ‚น305.81-10.53%
2016-โ‚น341.79375%
2015-โ‚น71.96-85.19%
2014-โ‚น485.7042.11%
2013-โ‚น341.7926.67%
2012-โ‚น269.83-6.25%
2011-โ‚น287.8214.28%
2010-โ‚น251.85100%
2009-โ‚น125.92-0%
2008-โ‚น125.92-33.33%
2007-โ‚น188.88-0%
2006-โ‚น188.884445.07%
2005-โ‚น4.16

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
BioCryst Pharmaceuticals
BCRX
-โ‚น4.50-92.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
โ‚น190.68-416.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
โ‚น586.44-1,073.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น267.14-543.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
โ‚น683.02-1,233.40%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚น323.44-636.71%๐Ÿ‡ฌ๐Ÿ‡ง UK